GO
Loading...

John Paulson on Allergan as Valeant takeover target

Wednesday, 16 Jul 2014 | 2:00 PM ET

John Paulson, founder of hedge fund firm Paulson & Co., said Allergan shares could be worth $222 a share as a result of a potential takeover by Valeant.